Polish chapter of “Chambers Acquisition Finance 2021 Global Practice Guide” authored by Dr. Marcin Olechowski, Borys D. Sawicki, Piotr Andrzejak and Witold Kurek

We are pleased to announce that IFLR1000 ranking recommended us in the following categories: Banking M&A Project finance Project development:…

SK&S M&A team advised renewable energy producer Sunly Land AS, based in Tallinn, Estonia, who joined forces with Alseva Group…

We would like to draw your attention to the upcoming deadline for submission of a statement on transfer pricing documentation…

Download PDF version Which goods are subject to regulatory and excise tax obligations? Regulatory and excise tax obligations pertain in…

Sołtysiński Kawecki & Szlęzak law firm is currently advising Euricom S.p.A., a prominent global leader in the rice sector, on…

SK&S lawyers have been recognised by ITR (International Tax Review) – a prestigious World Tax ranking! Piotr Andrzejak | Indirect…

Polish civil procedure is in the midst of a very significant makeover. The bulk of amendments came into effect on…

SK&S’ transactions and tax teams advised the shareholders of Brand New Galaxy on the sale transaction of their 100% shareholding…

Our team including: Dr Marcin Olechowski, Dr Wojciech Iwański, Borys Sawicki, Mateusz Blocher and Jan Pierzgalski published the Polish chapters…

Sołtysiński Kawecki & Szlęzak provided comprehensive advice to the Iliad Group and the companies in the group, Play Communications S.A….

Download the PDF version Under an understanding with the EU Commission the Polish Ministry of Finance intends to introduce amendments…

We have been recommended as one of the best law firms in 14 categories by The Legal500 EMEA 2024 ranking,…

SK&S lawyers have been recognised by ITR (International Tax Review) – a prestigious World Tax ranking! Sławomir Łuczak | General…

Sołtysiński Kawecki & Szlęzak has been ranked in the World Tax by the International Tax Review in 2 practice areas:…

SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of its first site…